Literature DB >> 9368137

The effects of calcium phosphate particles on the growth of osteoblasts.

J S Sun1, Y H Tsuang, C J Liao, H C Liu, Y S Hang, F H Lin.   

Abstract

With advances in ceramics technology, calcium phosphate bioceramics have been applied as bone substitutes for several decades. The focus of this work is to elucidate the biocompatibility of the particulates of various calcium phosphate cytotoxicities. Four different kinds of calcium phosphate powders, including beta-tricalcium phosphate (beta-TCP), hydroxyapatite (HA), beta-dicalcium pyrophosphate (beta-DCP), and sintered beta-dicalcium pyrophosphate (SDCP), were tested by osteoblast cell culture. The results were analyzed by cell count, concentration of transforming growth factor-beta 1 (TGF-beta 1), alkaline phosphatase (ALP), and prostaglandin E2 (PGE2) in culture media. The changes were most significant when osteoblasts were cultured with beta-TCP and HA bioceramics. The changes in cell population of the beta-TCP and HA were quite low in the first 3 days, then increased gradually toward the seventh day. The changes in TGF-beta 1 concentration in culture medium inversely related to the changes in cell population. The ALP titer in the culture media of the beta-TCP and HA were quite high in the first 3 days, then decreased rapidly between the third and seventh days. The concentrations of PGE2 in the culture media tested were quite high on the first day, decreased rapidly to the third day, and then gradually until the seventh day. The changes in the beta-DCP and SDCP were quite similar to those of HA and beta-TCP but much less significant. We conclude that HA and beta-TCP have an inhibitory effect on the growth of osteoblasts. The inhibitins effects of the HA and beta-TCP powders on the osteoblast cell cultures possibly are mediated by the increased synthesis of PGE2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368137     DOI: 10.1002/(sici)1097-4636(19971205)37:3<324::aid-jbm3>3.0.co;2-n

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  13 in total

1.  Effect of carbonate content and buffer type on calcium phosphate formation in SBF solutions.

Authors:  S Jalota; S B Bhaduri; A C Tas
Journal:  J Mater Sci Mater Med       Date:  2006-08       Impact factor: 3.896

2.  Crystallization behavior of silica-calcium phosphate biocomposites: XRD and FTIR studies.

Authors:  C Q Ning; Y Greish; A El-Ghannam
Journal:  J Mater Sci Mater Med       Date:  2004-11       Impact factor: 3.896

3.  Effects of silica on the bioactivity of calcium phosphate composites in vitro.

Authors:  C Q Ning; J Mehta; A El-Ghannam
Journal:  J Mater Sci Mater Med       Date:  2005-04       Impact factor: 3.896

4.  Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis.

Authors:  Siddharth P Pathi; Debra D W Lin; Jason R Dorvee; Lara A Estroff; Claudia Fischbach
Journal:  Biomaterials       Date:  2011-04-20       Impact factor: 12.479

5.  Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration.

Authors:  Vera Luginbuehl; Esther Wenk; Annette Koch; Bruno Gander; Hans P Merkle; Lorenz Meinel
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

6.  Growth of human osteoblast-like cells on beta-tricalciumphosphate (TCP) membranes with different structures.

Authors:  M Wiedmann-Al-Ahmad; R Gutwald; N-C Gellrich; U Hübner; R Schmelzeisen
Journal:  J Mater Sci Mater Med       Date:  2007-04       Impact factor: 3.896

7.  The first clinical trial of beta-calcium pyrophosphate as a novel bone graft extender in instrumented posterolateral lumbar fusion.

Authors:  Jae Hyup Lee; Bong-Soon Chang; Ul-Oh Jeung; Kun-Woo Park; Min-Seok Kim; Choon-Ki Lee
Journal:  Clin Orthop Surg       Date:  2011-08-19

8.  Preparation of laminated poly(ε-caprolactone)-gelatin-hydroxyapatite nanocomposite scaffold bioengineered via compound techniques for bone substitution.

Authors:  Azhang Hamlekhan; Fathollah Moztarzadeh; Masoud Mozafari; Mahmoud Azami; Nader Nezafati
Journal:  Biomatter       Date:  2011 Jul-Sep

9.  Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.

Authors:  Yi-Jie Kuo; Fon-Yih Tsuang; Jui-Sheng Sun; Chi-Hung Lin; Chia-Hsien Chen; Jia-Ying Li; Yi-Chian Huang; Wei-Yu Chen; Chin-Bin Yeh; Jia-Fwu Shyu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Biocompatibility of Poly-epsilon-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells.

Authors:  Haiying Yu; Paul H Wooley; Shang-You Yang
Journal:  J Orthop Surg Res       Date:  2009-02-26       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.